Acquisition by Mark Field of 3600 shares of Insulet subject to Rule 16b-3 Filed transaction by Insulet Officer Svp Chief Technology Officer. Grant, award or other acquisition pursuant to Rule 16b-3

Acquisition by Mark Field of 3600 shares of Insulet subject to Rule 16b-3

PODD Stock  USD 326.64  5.28  1.64%   
About 67 percent of all Insulet's shareholders are curious in acquiring. The analysis of overall sentiment of trading Insulet stock suggests that quite a large number of investors are confidant at this time. The current market sentiment, together with Insulet's historical and current headlines, can help investors time the market. In addition, many technical investors use Insulet stock news signals to limit their universe of possible portfolio assets.
Filed transaction by Insulet Officer Svp Chief Technology Officer. Grant, award or other acquisition pursuant to Rule 16b-3

Read at macroaxis.com
Insulet insider trading alert for acquisition of common stock by Mark Field, Officer: Svp & Chief Technology Officer, on 21st of May 2024. This event was filed by Insulet with SEC on 2024-02-27. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Insulet's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Insulet's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Insulet Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Insulet can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Insulet Historical Investor Sentiment

Investor biases related to Insulet's public news can be used to forecast risks associated with an investment in Insulet. The trend in average sentiment can be used to explain how an investor holding Insulet can time the market purely based on public headlines and social activities around Insulet. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Insulet's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Insulet and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Insulet news discussions. The higher the estimate score, the more favorable the investor's outlook on Insulet.

Insulet Maximum Pain Price Across July 18th 2025 Option Contracts

Insulet's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Insulet close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Insulet's options.

Insulet Fundamental Analysis

We analyze Insulet's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Insulet using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Insulet based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Net Asset

Net Asset Comparative Analysis

Insulet is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Insulet Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Insulet stock to make a market-neutral strategy. Peer analysis of Insulet could also be used in its relative valuation, which is a method of valuing Insulet by comparing valuation metrics with similar companies.

Peers

Insulet Related Equities

IARTIntegra LifeSciences   6.67   
0%
100.0%
SENSSenseonics Holdings   5.88   
0%
88.0%
MASIMasimo   4.74   
0%
71.0%
ALGNAlign Technology   4.54   
0%
68.0%
TNDMTandem Diabetes   3.67   
0%
55.0%
TMDXTransMedics   3.44   
0%
51.0%
INMDInMode   2.18   
0%
32.0%
SYKStryker   1.90   
0%
28.0%
PENPenumbra   1.52   
0%
22.0%
DXCMDexCom   0.97   
0%
14.0%
EWEdwards Lifesciences   0.27   
0%
4.0%
INSPInspire Medical   0.04   
1.0%
0%
ABTAbbott Laboratories   0.15   
2.0%
0%
GKOSGlaukos Corp   1.20   
17.0%
0%

Complementary Tools for Insulet Stock analysis

When running Insulet's price analysis, check to measure Insulet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insulet is operating at the current time. Most of Insulet's value examination focuses on studying past and present price action to predict the probability of Insulet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insulet's price. Additionally, you may evaluate how the addition of Insulet to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Bonds Directory
Find actively traded corporate debentures issued by US companies
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals